跳至主要内容
临床试验/EUCTR2014-000727-25-NL
EUCTR2014-000727-25-NL进行中(未招募)1 期

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial.

Isala Klinieken0 个研究点开始时间: 2017年3月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • All female patients older than 18 years, who will undergo a breast reconstruction with a LD flap will be included. All participating patients have to sign a written consent, before they can be included in our study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 118
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who are pregnant, have a pre-operative on-going infection, history of systemic anti-coagulant use, known hypersensitivity to ARTISS or postoperative haemorrhage will be excluded.

研究者

发起方
Isala Klinieken

相似试验